









Markets
/
Stocks
/
nasdaq-neo
/

Neogenomics Inc

NEO

View Detailed Chart

5.351USD

+0.191+3.70%

Market hours （ET）Quotes delayed by 15 min

688.54MMarket Cap

LossP/E TTM



Neogenomics Inc

5.351

+0.191+3.70%

Overview Company Financials

Financials

Intraday

30m

Today

+3.70%

5 Days

-14.93%

1 Month

-29.13%

6 Months

-61.45%

Year to Date

-67.53%

1 Year

-68.84%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 15 analysts

HOLD

Current Rating

8.545

Target Price

65.61%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Neogenomics Inc

NEO

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(0)

Buy(1)

Indicators

Sell(4)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.333

Sell

RSI(14)

29.524

Sell

STOCH(KDJ)(9,3,3)

16.611

Oversold

ATR(14)

0.452

High Vlolatility

CCI(14)

-123.286

Sell

Williams %R

82.540

Oversold

TRIX(12,20)

-1.013

Sell

StochRSI(14)

42.847

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

5.362

Sell

MA10

5.876

Sell

MA20

6.488

Sell

MA50

6.989

Sell

MA100

8.002

Sell

MA200

11.360

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

Ticker SymbolNEO

CompanyNeogenomics Inc

CEOMr. Antony P. Zook

Websitehttps://neogenomics.com/